COO
The Cooper Companies, Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$69.82
−1.16%Year over year
Reported trailing growth
- Revenue
- +6.1%
- EBITDA
- -21.2%
- EBIT
- -34.3%
- EPS
- -43.2%
- Free cash flow
- +55.6%
- Operating cash flow
- +25.0%
Forward estimates
Based on analyst estimates
- Revenue
- +5.4%
- EBITDA
- +97.4%
- EPS
- +314.2%
Three-year CAGR
- Revenue
- +7.3%
- EBITDA
- +6.2%
- EBIT
- +10.4%
- Net income
- -1.0%
- EPS
- -1.4%
- Free cash flow
- -1.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Apr 1, 2026